Dr. Matthew Hill
π€ SpeakerAppearances Over Time
Podcast Appearances
And yeah, so the Charlotte's Web was like, I believe that was what they had named that kind of cannabis that they'd extracted it from. And so it was this, it was a tincture that they were using that was very high CBD content that they were finding was controlling pediatric seizures in kids. Now, this has actually been studied pretty effectively. Most of it's come out of Boston.
Elizabeth Thiel said, has been one of the main leads on this, and she's a neurologist there that has done a lot of the work on this. And so they have, I think, very clearly, and the data is incredibly compelling, their research is one of the reasons why CBD has been descheduled or changed in its scheduling down to a, what is it, a five? What is it, class? CBD? Yeah, like CBD.
Elizabeth Thiel said, has been one of the main leads on this, and she's a neurologist there that has done a lot of the work on this. And so they have, I think, very clearly, and the data is incredibly compelling, their research is one of the reasons why CBD has been descheduled or changed in its scheduling down to a, what is it, a five? What is it, class? CBD? Yeah, like CBD.
Elizabeth Thiel said, has been one of the main leads on this, and she's a neurologist there that has done a lot of the work on this. And so they have, I think, very clearly, and the data is incredibly compelling, their research is one of the reasons why CBD has been descheduled or changed in its scheduling down to a, what is it, a five? What is it, class? CBD? Yeah, like CBD.
So it's been kind of a lot of it's been like shifted in its classification status because it actually has been shown very clearly to have medical benefit. And so it was very specific. It was a very specific form of pediatric epilepsy called Dravet syndrome. Now, there's other forms of pediatric epilepsy I know Elizabeth has studied in addition that has found comparable levels of efficacy.
So it's been kind of a lot of it's been like shifted in its classification status because it actually has been shown very clearly to have medical benefit. And so it was very specific. It was a very specific form of pediatric epilepsy called Dravet syndrome. Now, there's other forms of pediatric epilepsy I know Elizabeth has studied in addition that has found comparable levels of efficacy.
So it's been kind of a lot of it's been like shifted in its classification status because it actually has been shown very clearly to have medical benefit. And so it was very specific. It was a very specific form of pediatric epilepsy called Dravet syndrome. Now, there's other forms of pediatric epilepsy I know Elizabeth has studied in addition that has found comparable levels of efficacy.
But essentially what they have shown is that like very high doses of CBD are are relatively effective at calming down the seizures. In some kids, it's profound. Like in some kids, you're talking about kids that were having dozens of seizures a day to essentially none.
But essentially what they have shown is that like very high doses of CBD are are relatively effective at calming down the seizures. In some kids, it's profound. Like in some kids, you're talking about kids that were having dozens of seizures a day to essentially none.
But essentially what they have shown is that like very high doses of CBD are are relatively effective at calming down the seizures. In some kids, it's profound. Like in some kids, you're talking about kids that were having dozens of seizures a day to essentially none.
And so, and I can understand, I mean, from a grassroots perspective, I can understand if you were a parent who had a child with a disease like this that was largely intractable and not that well controlled from the medications they were on, and then something came around that showed this level of efficacy, you would gravitate towards it. Like, that makes sense to me.
And so, and I can understand, I mean, from a grassroots perspective, I can understand if you were a parent who had a child with a disease like this that was largely intractable and not that well controlled from the medications they were on, and then something came around that showed this level of efficacy, you would gravitate towards it. Like, that makes sense to me.
And so, and I can understand, I mean, from a grassroots perspective, I can understand if you were a parent who had a child with a disease like this that was largely intractable and not that well controlled from the medications they were on, and then something came around that showed this level of efficacy, you would gravitate towards it. Like, that makes sense to me.
And I think the work that Elizabeth and her colleagues have done has been really important to establish the efficacy of this, of CBD in these communities. disease states. And so I don't think at this point there's a lot of controversy around that. The question that comes out though is, so how is it working? And we don't have a mechanism.
And I think the work that Elizabeth and her colleagues have done has been really important to establish the efficacy of this, of CBD in these communities. disease states. And so I don't think at this point there's a lot of controversy around that. The question that comes out though is, so how is it working? And we don't have a mechanism.
And I think the work that Elizabeth and her colleagues have done has been really important to establish the efficacy of this, of CBD in these communities. disease states. And so I don't think at this point there's a lot of controversy around that. The question that comes out though is, so how is it working? And we don't have a mechanism.
So as you had said, like CBD receptor, there is no CBD, like there's no receptor that CBD binds to.
So as you had said, like CBD receptor, there is no CBD, like there's no receptor that CBD binds to.
So as you had said, like CBD receptor, there is no CBD, like there's no receptor that CBD binds to.
Like you can certainly, I mean, you can have products that are made that are like oil-based products, at least, that have a certain amount of CBD and a certain amount of THC. And people do go for those. And there's this β I mean one of the arguments people make is they say, oh, introducing CBD reduces the adverse effects of THC.